secwatch.observer — SEC 8-K summary
======================================

Issuer:     MIRA PHARMACEUTICALS, INC. (MIRA)
CIK:        0001904286
Form:       8-K
Filed at:   2023-12-01T23:59:59+00:00
Accession:  0001493152-23-043441
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Mira Pharmaceuticals: Director Brian Daly resigns; Michael Jerman becomes Audit Committee Chair
--------------------------------------------------------------------------------

- Brian Daly resigned from the Board effective December 1, 2023; he had served as Audit Committee Chair and Compensation Committee member.
- Michael Jerman appointed Chairman of the Audit Committee on December 1, 2023; had been appointed to the committee on November 14, 2023.
- Daly's resignation was not due to any disagreement with the Company, management, or Board on operations, policies, or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1904286/000149315223043441/0001493152-23-043441-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1904286/000149315223043441/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-043441

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer